Web18 de mar. de 2015 · Existing chronic bone pain prior to pegfilgrastim usage. Creatinine clearance of <50ml/minute by Cockcroft Gault equation. Allergy to filgrastim, pegfilgrastim, or Loratadine. ... Bone pain Pegfilgrastim Neulasta PEG-G-CSF Loratadine Placebo Sugar pill Questionnaires Surveys: Web5 de nov. de 2016 · Those who developed bone pain received prophylaxis at their next G-CSF dose with a combination of famotidine and loratadine. The primary endpoint was to determine the analgesic effects of double histamine blockade for G-CSF induced bone pain. The secondary endpoint was to determine potential risk factors for the development of …
Loratadine and Naproxen and Chemotherapy on Bone Pain in …
Web19 de out. de 2012 · Bone Pain in Stage I - III Breast Cancer Intervention / Treatment Drug: Loratadine Drug: Naproxen Biological: Pegfilgrastim Drug: Chemotherapy Detailed Description In this study, the investigational products are naproxen, a non-steroidal antiinflammatory drug (NSAID), and loratadine, an anti-histamine. Web14 de jan. de 2008 · Although the role of G-CSF in histamine release is unclear, this concept could be the basis for anecdotal use of antihistamines to treat G-CSF-induced bone pain. Furthermore, second-generation ... crgw plymouth address
Facebook - National Cancer Institute
WebBone pain is one of the common side effects of G-CSF. There are multiple strategies to alleviate the pain, though there is a lack of evidence. A pilot study was conducted to examine the efficacy of an oral antihistamine (loratadine) in the management of bone pain induced by G-CSF. Web22 de nov. de 2024 · Histamine blockade with Loratadine in the prevention of bone pain induced by G-CSF did not show statistically significant advantage over placebo or no prophylaxis. Clinical trial identification Editorial acknowledgement Legal entity responsible for the study The authors. Funding Has not received any funding. Disclosure Web16 de nov. de 2024 · A recent study by Gavioli et al. reported that double histamine blockade (using a combination of famotidine and loratadine) was effective in alleviating bone pain secondary to G-CSF use . The present study was a prospective, randomized, three-arm trial conducted in 600 patients. crgw ivf